News Conference News TCT 2016 Are Full, Formal Guidelines Still Useful in the Rapidly Changing TAVR Field? Todd Neale October 30, 2016
Presentation TCT 2016 Summary and Rationale For the ACC-AHA Guidelines on DAPT Duration After PCI Presenter: John A. Bittl, Daniel I. Simon, Glenn N. Levine October 30, 2016
Presentation TCT 2016 Future TAVR Guidelines: The Next ACC/AHA TAVR Focused Update and New Appropriate Use Criteria for TAVR Presenter: Patrick T. O'Gara, Alec S. Vahanian, Samir R. Kapadia October 30, 2016
Presentation TCT 2015 Intervention for Tricuspid Regurgitation: What Do the Guidelines Say? (ACC/AHA and ESC/EACTS) Presenter: Rebecca T. Hahn, Joachim Schofer, Alec S. Vahanian October 15, 2015
Presentation TCT 2015 What Defines Severe MR Post-AHA/ACC Guidelines? Presenter: Jeroen J. Bax, Paul A. Grayburn October 15, 2015
Presentation TCT 2014 Guideline Update: Aortic and Mitral Valve Disease and the 2014 AHA/ACC Guideline for Valvular Heart Disease Presenter: Blase A. Carabello, George D. Dangas, Patrick T. O'Gara September 15, 2014
News Conference News TCT 2014 PFO Closure for Stroke: A Call to Revise the Guidelines September 14, 2014
Presentation TCT 2014 ASA/AHA Guidelines 2014: PFO Closure for Cryptogenic Stroke Is Now Class III LOE A! Is This the Final Word from the Neurology Community? Presenter: Matthew J. Price, Mark Reisman, Sheldon Goldberg, David E. Thaler September 13, 2014
Presentation TCT 2014 Important Changes in the New 2014 ACC/AHA Aortic Valve Guidelines: Aligning Definitions of Aortic Stenosis Severity with Treatment Recommendations Presenter: A. Pieter Kappetein, Martin B. Leon, Howard C. Herrmann, Robert O. Bonow September 13, 2014
News Conference News TCT 2013 High-Dose Statins before PCI Improved Outcomes in NSTE-ACS November 06, 2013
Presentation TCT 2013 Introduction and AHA Policy Statement Presenter: H. Robert Superko October 31, 2013
News Conference News TCT 2013 In Memoriam: Andreas Gruentzig, MD, Receives TCT Career Achievement Award October 29, 2013
Presentation TCT 2013 Distilling the Aortic Stenosis Guidelines (Synthesis of ESC and ACC/AHA): Essentials and Controversies Presenter: Alec Vahanian October 27, 2013
Presentation TCT 2013 Discontinuation of Long-Term Clopidogrel Therapy is Associated with Death and Myocardial Infarction after Saphenous Vein Graft Percutaneous Coronary Intervention Presenter: Amit Sachdeva, Sumati Bavisetty, Gerald Beckham, Albert Shen, Vicken Aharonian, Prakash Mansukhani, Gregg Stone, Martin Leon, Jeffrey Moses, Naing Moore, Ric Hyett, Richard Contreras, Somjot Brar January 31, 2013
Presentation TCT 2012 Atrial Fibrillation: 1. CHADS2 vs. CHA2DS2-VASc Risk Assessment. 2. AHA/ACC vs. ACCP/ESC Approach to Stroke Prevention. Presenter: Peter Brady October 23, 2012
Presentation TCT 2012 The Association Between Duration of Clopidogrel Therapy After Saphenous Vein Graft Intervention And Long-Term Death And Myocardial Infarction Presenter: Amit Sachdeva, Sumati Bavisetty, Gerald Beckham, Vicken Aharonian, Prakash Mansukhani, Gregg W. Stone, Naing Moore, Ric Hyett, Richard Contreras, Somjot S. Brar January 03, 2012
Presentation TCT 2012 Long-term Mortality After Aortic Dissection in the Community - Results from the Kaiser Permanente Registry of Aortic Dissections (KP-RAD) Presenter: Cuong Lam, Jackie Schwartz, Kevin Izquierdo, Aman Saw, Vicken Aharonian, Kevin Patel, Raymond Chen, George Vatakencherry, Michael Jorgensen, Kwok Yun, William Gray, Somjot S. Brar January 03, 2012
Presentation TCT 2012 Determining a Troponin I Threshold for Predicting 30-Day Mortality: Results from the Troponin I In the Emergency Room (TiER) Study Presenter: Saman Fakheri, Albert Shen, Steven Khan, Prakash Mansukhani, Vicken Aharonian, Richard Contreras, Michael Jorgensen, Somjot S. Brar January 03, 2012